Together, these data suggest that inhibition of the protein kinases TBK1 and IKKε by amlexanox upregulates bile acid production to increase cholesterol excretion and thus ameliorates hypercholesterolemia. The gene discussed is IKBKE; the disease is familial hypercholesterolemia.